Keywords: Pancreas, Pancreas, MRCP with secretin
Motivation: To improve MRCP with Secretin variability in determining exocrine pancreatic function (ePFT).
Goal(s): To develop and assess a model for assessing ePFT based on MRCP with secretin modulation
Approach: A retrospective study evaluating our new model compared to serum fecal elastase (FE) or ePFT. A reader-study was performed to assess radiologist variability.
Results: 1) There was moderate agreement between radiologists in our reader study. 2) There was no correlation in any model derived variable and FE or between FE and ePFT. 4) There was a statistically significant difference in kappa delay derived from our model and ePFT.
Impact: This novel paradigm may be a more effective comparator for ePFT in patients
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords